From Newborns to Older Adults
UNCOVER THE REALITY OF RSV
DISCOVER WHO IS AT RISK OF SERIOUS COMPLICATIONS
Respiratory syncytial virus (RSV) is a common, highly contagious virus that can compromise the lungs and breathing passages.1
RSV is most severe in young infants and older adults, for whom serious lung infections can lead to hospitalizations and may be life-threatening.2,3
Who’s at high risk for severe RSV infection?
Premature infants
and infants (≤ 6 months)1
Children (< 2 years) with
chronic medical conditions1
Older adults
(≥ 65 years)4
People with an immunodeficiency1,4
People with certain underlying conditions1,4
Such as chronic cardiopulmonary disease
The impact of RSV
RSV is a highly contagious virus with potentially severe outcomes.
Learn more about the burden of RSV
References :
1. Centers for Disease Control and Prevention (CDC). RSV in infants and young children. Updated October 2020. Accessed April 18, 2023. https://www.cdc.gov/rsv/downloads/RSV-in-Infants-and-Young-Children.pdf. 2. Ontario Ministry of Health and Ministry of Long-Term Care. Accessed April 18, 2023. https://www.health.gov.on.ca/en/pro/programs/drugs/funded_drug/fund_respiratory.aspx. 3. Government of Canada. Respiratory syncytial virus (RSV): for health professionals. Accessed April 18, 2023. https://www.canada.ca/en/public-health/services/diseases/respiratory-syncytial-virus-rsv/health-professionals.html. 4. Centers for Disease Control and Prevention (CDC). Older adults are at high risk for severe RSV infection. Updated October 2020. Accessed April 18, 2023. https://www.cdc.gov/rsv/factsheet-older-adults.pdf.
This site is intended for Canadian healthcare professionals only.
© 2023 Pfizer Canada ULC, Kirkland, Quebec H9J 2M5 | PP-A1G-CAN-0006-EN
© 2023 Pfizer Canada ULC, Kirkland, Quebec H9J 2M5 PP-A1G-CAN-0006-EN
